Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Ljubljana Stock Exchange  >  Krka, d. d.    KRKG   SI0031102120

KRKA, D. D.

(KRKG)
  Report
End-of-day quote. End-of-day quote Ljubljana Stock Exchange - 01/15
96.2 EUR   -0.82%
2020KRKA D D : Reports Business Results for the First Nine Months Ended 30 September 2020
PU
2020KRKA, D. D. : quaterly earnings release
2020KRKA, D. D. : Ex-dividend day for final dividend
FA
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Strengths
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • Historically, the company has been releasing figures that are above expectations.
  • This company will be of major interest to investors in search of a high dividend stock.
  • Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • Within the weekly time frame the stock shows a bullish technical configuration above the support level at 77 EUR
Weaknesses
  • The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.
  • The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.
Ratings chart
Sector Generic Pharmaceuticals
1st jan.Capitalisation (M$)Investor Rating
KRKA, D. D.5.25%3 642
OTSUKA HOLDINGS CO., LTD.-0.09%23 063
SUN PHARMACEUTICAL INDUSTRI..2.02%19 821
SHANGHAI FOSUN PHARMACEUTIC..-7.21%18 140
ONO PHARMACEUTICAL CO., LTD..-1.06%14 787
DIVI'S LABORATORIES LIMITED-5.13%13 228
ZHEJIANG NHU COMPANY LTD.12.14%12 524
CIPLA LIMITED0.46%9 081
CADILA HEALTHCARE LIMITED2.32%6 827
TAISHO PHARMACEUTICAL HOLDI..1.29%5 414
SHIJIAZHUANG YILING PHARMAC..12.71%5 293
RICHTER GEDEON VEGYÉSZETI G..6.52%4 937
SHENZHEN SALUBRIS PHARMACEU..8.26%4 868
ASPEN PHARMACARE HOLDINGS L..15.25%4 334
SICHUAN KELUN PHARMACEUTICA..-6.33%4 019
HANMI PHARM. CO., LTD.-1.64%3 923
More Results
Financials
Sales 2020 1 563 M 1 889 M 1 889 M
Net income 2020 255 M 307 M 307 M
Net cash 2020 309 M 373 M 373 M
P/E ratio 2020 12,4x
Yield 2020 4,50%
Capitalization 3 012 M 3 642 M 3 640 M
EV / Sales 2020 1,73x
EV / Sales 2021 1,67x
Nbr of Employees 11 503
Free-Float 67,3%
Upcoming event on KRKA, D. D.
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation -
Finances -
Profitability -
Earnings quality
Business Predictability
P/E ratio -
Potential
Yield
Consensus
7 days EPS revision -
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes